Tuesday - June 9, 2026
University of Houston: Dual-Target Drug Tackles Immunotherapy Resistance in Pancreatic Cancer
May 28, 2026
HOUSTON, Texas, May 28 (TNSjou) -- The University of Houston issued the following news:

* * *

New Dual-Target Drug Tackles Immunotherapy Resistance in Pancreatic Cancer

University of Houston Researcher Part of Groundbreaking National Study

By Laurie Fickman -- (713) 743-8454, lafickman@uh.edu

A national team of researchers is reporting a new strategy to treat pancreatic cancer -- by boosting the immune system. Pancreatic ductal ade . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products